Navigation Links
Alzheimer's drug market to hit $5.5 billion by 2009, study says

Toronto-based Millennium Research Group predicts the Alzheimer's disease drug market in the United States, Europe and Japan will grow by 15 percent annually for the next five years.

Pharmaceutical manufacturers profiled in Millennium's study, entitled "Global Markets for Alzheimer's Disease Medications 2005," include Pfizer, Shire Pharmaceuticals and Novar......

Full article >>>
'"/>

Source:wistechnology.com By Lincoln Brunner 05/16/05


Page: 1 2

Related biology technology :

1. Alzheimers drug developer lands $1.2M in venture funding
2. Biotech firm has strokes, Alzheimers in its sights
3. Mithridion wins grants for Alzheimers research
4. Alzheimers drug firm and more winners named in Wisconsin business-plan contest
5. Marshfield study mixes DNA into electronic medical record to screen for Alzheimers
6. UW Alzheimers researchers found company; privacy law; Science Expeditions
7. Madison-based Mithridion seeks to capitalize on Alzheimers breakthrough
8. Discovery may halt progression of Alzheimers
9. Reforming FDA: Focus on safety, let market judge efficacy
10. Internet-enabled niche markets take center stage
11. GE Healthcare leads compact ultrasound market
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Alzheimer drug market hit billion study says